Study: NCT01416363

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast immediate release tablet
Description: Firategrast immediate release tablet is white to pale cream colored 300 mg unit dose and subjects will administer it with 240 milliliter (mL) of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast modified release tablet
Description: Firategrast modified release tablet is white to slightly colored 600 mg unit dose and subjects will administer it with 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firategrast gastro-retentive solution
Description: Firategrast solution is clear colorless solution and subject will administer it via nasogastric route.